HCP5 and thyroid gland follicular carcinoma: The HLA complex P5 (HCP5) is a cancer-related lncRNA and has been investigated in breast cancer22, follicular thyroid carcinoma (FTC)23, lung adenocarcinoma (LUAD)24, glioma25, and GC26.